This page to be completed
In the near future, this page will be populated with information about the CHILD Cohort Study’s policies and procedures.
CHILD Cohort Study Data User Responsibility Checklist
A completed CHILD Cohort Study Data User Responsibility Checklist, available below, must be included with each Publication Proposal submission. See details here.
The CHILD Cohort Study adheres to the ICMJE authorship guidelines, which require:
- substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data; AND
- substantial contributions to thedrafting the work or revising it critically for important intellectual content; AND
- substantial contributions to thefinal approval of the version to be published; AND
- substantial contributions to theagreement to be accountable for all aspects of the work.
In alignment with these guidelines, the CHILD Study Director and Site Leaders are to be offered authorship on all manuscripts using CHILD data. This reflects their substantial contributions to the study’s design and governance, participant recruitment and retention, data acquisition and analysis, and long-term oversight of cohort infrastructure, which fulfill criterion 1. To satisfy the remaining criteria (2, 3, and 4), they must be given the opportunity to engage in manuscript drafting or revision and to review and approve the final version prior to submission.
For CHILD Cohort Study (CHILD) microbiome data, researchers can access the publicly available raw sequencing reads deposited in various BioProjects. These datasets offer a flexible and rigorous starting point for high-quality microbiome research.
Integration of microbiota sequencing data with clinical endpoints, demographic data, environmental exposures, and other microbiota-associated profiles, such as stool metabolomics, is still supported through CHILDdb.
Raw microbiome datasets from CHILD currently available through BioProjects
| Data/Sample Type | Timepoint(s) | Sequencing Type | BioProject ID |
| Raw nasal microbiome data | 3M and 1Y | (16S rRNA gene sequencing) | PRJNA1127065 |
| Raw gut microbiome data | 3M and 1Y | (16S rRNA gene sequencing) | PRJNA657821 |
| Raw gut microbiome data | 3M and 1Y | (shotgun metagenomics) | PRJNA838575 |
| Raw milk microbiome data | 3M | (16S rRNA gene sequencing) | PRJNA481046 and PRJNA597997 |
- Technical Data: Minimal technical data (batch, exact age at sampling, visit number, and time from sample collection to long-term storage) are freely available upon request. Researchers may obtain this information by contacting the corresponding authors of the associated manuscripts or by emailing child@mcmaster.ca.
- Preprocessing Methods: Detailing preprocessing steps are available within published manuscripts citing these BioProjects. Depending on the age of the study, in some instances related code may also be available from the corresponding authors upon request.
- Data Linkage: Linkage of the samples to CHILD participant IDs and all other CHILD variables (including clinical endpoints, demographic data, and environmental exposures) will continue to require completion of the standard concept proposal process within CHILDdb.
Branding Guidelines
When writing about or representing the CHILD Cohort Study, please respect the Study’s brand.
The CHILD Cohort Study’s Branding Guidelines provide information about the proper use of the Study’s name, logos, tagline, colour palette, and other details.
The Study’s primary logo can be downloaded from this page. For other logos, templates and CHILD-branded materials, contact CHILD as indicated in the Guidelines.
The Guidelines can be downloaded in PDF from this page
.
Media protocol
The document below outlines a protocol for CHILD Cohort Study researchers to follow when dealing with the media to promote CHILD findings arising from a published research paper.
Guidelines for media interactions are essential to ensure that the CHILD Cohort Study, its research results, and its brand are professionally and consistently represented.
Close collaboration between the paper’s senior (corresponding) author, his or her institution and the AllerGen/CHILD Communications team is essential when planning and implementing public announcements of CHILD research findings.